QUAD SHOT Palliative Radiotherapy – From Current Evidence to Future Perspectives
Journal of Medical and Radiation Oncology · 10.11.2026 · 6 (1) · 33-38
DOI: 10.53011/jmro.2026.01.02 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical and Radiation Oncology, online erschienen am 31.10.2026. Verfasst von Mara Răzniceanu und 2 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Palliative radiotherapy provides effective symptom control for patients with advanced or metastatic cancer ineligible for curative treatment. Short hypofractionated regimens are preferred for frail patients to minimize treatment burden. The QUAD SHOT regimen delivers 14–14.8 Gy in four twice-daily fractions over two consecutive days, repeatable at 3–4 week intervals, yet remains underutilized despite demonstrated efficacy. This narrative review synthesizes current evidence on QUAD SHOT radiotherapy, examining clinical outcomes, toxicity profiles, and feasibility in elderly populations. Across the studies reviewed, palliative or objective response rates ranged from approximately 44% to 94%, treatment-completion rates for all three cycles from 28% to 53%, and median overall survival from 3.5 to 6.3 months, with grade 3 or higher toxicity generally reported in 5% or fewer of patients in modern series. We evaluate the impact of modern radiation techniques (IMRT, VMAT, proton therapy) and explore emerging combination strategies with immunotherapy, where one retrospective series reported improved 12-month local control (85% vs 63%) without a corresponding overall survival benefit. While these preliminary data suggest promise, the predominance of retrospective studies and small series highlights the need for prospective validation and standardized protocols. Keywords: QUAD SHOT, palliative, radiotherapy, recurrent, metastatic, elderly, immunotherapy, hypofractionation
Zitieren
APA
Răzniceanu, M., Mirteștean, C. C., & Iancu, D. P. T. (2026). QUAD SHOT Palliative Radiotherapy – From Current Evidence to Future Perspectives. Journal of Medical and Radiation Oncology, 6(1), 33-38. https://doi.org/10.53011/jmro.2026.01.02
Vancouver
Răzniceanu M, Mirteștean CC, Iancu DPT. QUAD SHOT Palliative Radiotherapy – From Current Evidence to Future Perspectives. Journal of Medical and Radiation Oncology. 2026;6(1):33-38. doi:10.53011/jmro.2026.01.02
BibTeX
@article{Rzniceanu2026,
author = {Răzniceanu, Mara and Mirteștean, Camil Ciprian and Iancu, Dragoș Petru Teodor},
title = {QUAD SHOT Palliative Radiotherapy – From Current Evidence to Future Perspectives},
journal = {Journal of Medical and Radiation Oncology},
year = {2026},
volume = {6},
number = {1},
pages = {33--38},
doi = {10.53011/jmro.2026.01.02}
}
EUVIMED